Usana Health Sciences/USNA

$43.97

-2.93%
-
1D1W1MYTD1YMAX

About Usana Health Sciences

USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.

Ticker

USNA

Sector

Consumer Non-Cyclicals

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Kevin Guest

Employees

1,800

Headquarters

Salt lake city, United States

USNA Metrics

BasicAdvanced
$875.06M
Market cap
13.79
P/E ratio
$3.30
EPS
0.92
Beta
-
Dividend rate
$875.06M
0.91757
$69.60
$44.01
81.48K
3.515
2.998
0.158
8.792
10.38%
13.69%
13.2%
13.791
0.95
1.75
1.944
15.585
-7.77%
-8.1%
-6.72%
-17.47%

What the Analysts think about USNA

Analyst Ratings

Majority rating from 1 analysts.
Hold

Price Targets

Average projection from 2 analysts.
28.5% upside
High $65.00
Low $48.00
$43.97
Current price
$56.50
Average price target

USNA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.55% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$221M
3.61%
Net income
$16.7M
47.79%
Profit margin
7.55%
42.72%

USNA Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 68.77%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.95
$0.89
$0.59
$0.87
-
Expected
$0.77
$0.70
$0.64
$0.52
$0.69
Surprise
24.02%
27.97%
-7.31%
68.77%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Usana Health Sciences stock?

Usana Health Sciences (USNA) has a market cap of $875.06M as of April 13, 2024.

What is the P/E ratio for Usana Health Sciences stock?

The price to earnings (P/E) ratio for Usana Health Sciences (USNA) stock is 13.79 as of April 13, 2024.

Does Usana Health Sciences stock pay dividends?

No, Usana Health Sciences (USNA) stock does not pay dividends to its shareholders as of April 13, 2024.

When is the next Usana Health Sciences dividend payment date?

Usana Health Sciences (USNA) stock does not pay dividends to its shareholders.

What is the beta indicator for Usana Health Sciences?

Usana Health Sciences (USNA) has a beta rating of 0.92. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Usana Health Sciences stock price target?

The target price for Usana Health Sciences (USNA) stock is $56.5, which is 28.5% above the current price of $43.97. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Usana Health Sciences stock

Buy or sell Usana Health Sciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing